Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents
作者:Saleh I. Alqasoumi、Areej M. Al-Taweel、Ahmed M. Alafeefy、Mostafa M. Ghorab、Eman Noaman
DOI:10.1016/j.ejmech.2010.01.022
日期:2010.5
5 μg/mL) are more potent and efficacious than Doxorubicin (CAS-23214-92-8) as reference drug with (IC50 value = 37.5 μg/mL). Also, compounds 28, 30, 31, and 34 (with IC50 values = 25 μg/mL) are nearly as active as Doxorubicin.
本文介绍了一些新型的4-(2-氨基-3-氰基-4-(取代的芳基)-5-氧代-5,6,7,8-四氢喹啉-1(4H)-基)苯磺酰胺的合成(23 - 41)开始与4-(3-氧代-环己-1-烯基氨基)苯磺酰胺(3)。评价所有新合成的化合物的体外抗肿瘤活性。化合物32,25,41,35,33,和37与IC 50个值(2.5,3,5,10,12,和12.5微克/毫升)是更有效的和多柔比星相比(CAS-23214-92-8)有效作为参考药物与(IC 50值= 37.5μg/ mL)。另外,化合物28,30,31,和34(用IC 50个值= 25微克/毫升)几乎作为活性如多柔比星。